why choose us

Clinical Trials Search

Showing 15,440 of 132,963 result(s)
BIOSTREAM.HF HeartInsight

Status: COMPLETED

Condition: Heart Failure

Interventions: HeartInsight is activated at enrollment.
The attending physicians are free on how to integrate HeartInsight in the patient care.
Any treatme

Date: 2023-02-07

A Pilot Randomized Controlled Trial: CoINTEGRATE

Status: COMPLETED

Condition: Neurocognitive Disorders

Interventions:

Participants that score 1-1.5 standard deviation (SD) below the norm for age and education on 2 cognitive domains will receive an intensive program

Date: 2023-02-07

Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

Status: COMPLETED

Condition: Glioblastoma

Interventions: Neuronavigated targeted biopsy sampling.
Supramarginal resection including high-risk areas of recurrence defined by a radiomics-based model.

Date: 2023-02-07

Istradefylline Effect Protocol on Parkinson's Disease Tremor

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Istradefylline targets adenosine A2A receptors in the basal ganglia, by inhibiting the indirect pathway It is an adjunctive treatment to carbidopa-lev

Date: 2023-02-07

[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

Status: COMPLETED

Condition: Glioblastoma Multiforme of Brain

Interventions: Injection of the 18F-fluoropivalate (18F-FPIA) radiotracer followed by a whole brain static PET-CT scan.

Date: 2023-02-07

Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria

Status: COMPLETED

Condition: Auricular Fibrillation

Interventions: There are not intervention.

Date: 2023-02-07

Steroids in Occipital Nerve Block for Treatment of Headache

Status: COMPLETED

Condition: Headache

Interventions: 2 mL of bupivacaine 0.5% (5 mg;mL) injected at the origin of each bilateral greater and lesser occipital nerves

Date: 2023-02-07

Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR)

Status: COMPLETED

Condition: Retinopathy, Diabetic

Interventions:

Date: 2023-02-06

A Study to Learn How Linvoseltamab (REGN5458) Will Work Compared to the Elotuzumab, Pomalidomide and Dexamethasone (EPd) Combination, in Participants With Relapsed;Refractory Multiple Myeloma

Status: Completed

Condition: Relapsed Refractory Multiple Myeloma

Interventions: REGN5458 will be administered by intravenous (IV) infusion

Date: 2023-02-06